This inventor holds 4 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 1999-2001.
Company Filing History:
Years Active: 1999-2001
Title: Megan McHale McLaughlin: Innovator in Pharmaceutical Research
Introduction
Megan McHale McLaughlin is a notable inventor based in Drexel Hill, Pennsylvania. She has made significant contributions to the field of pharmaceutical research, holding a total of 4 patents. Her work focuses on the identification of pharmaceutically active compounds, particularly in relation to human brain phosphodiesterase.
Latest Patents
One of her latest patents involves the methods for identifying pharmaceutically active compounds related to CSBP/p38, a MAP kinase activated in response to various stressors. This research led to the cloning of a kinase designated MAPKAP kinase-3, which shares approximately 70% amino acid identity to MAPKAP kinase-2. The binding of CSBP to MAPKAP kinase-3 was confirmed through various in vitro and in vivo experiments, demonstrating its phosphorylation by CSBP1 and CSBP2. The findings suggest that MAPKAP kinase-3 is activated by stress and cytokines, making it a novel substrate of CSBP.
Career Highlights
Megan McHale McLaughlin is currently employed at SmithKline Beecham Corporation, where she continues her innovative work in pharmaceutical research. Her contributions have been instrumental in advancing the understanding of MAPKAP kinase-3 and its potential applications in drug discovery.
Collaborations
Throughout her career, she has collaborated with esteemed colleagues such as George P. Livi and Theodore J. Torphy. These collaborations have further enriched her research and expanded the impact of her inventions.
Conclusion
Megan McHale McLaughlin is a pioneering inventor whose work in pharmaceutical research has led to significant advancements in the identification of active compounds. Her contributions continue to influence the field and pave the way for future innovations.